Management of malignant bone tumors in children and adolescents.
D000293:Adolescent; D001859:Bone Neoplasms / Q000175:diagnosis / Q000601:surgery / Q000628:therapy*; D002648:Child; D003520:Cyclophosphamide / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004317:Doxorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis; D012516:Osteosarcoma / Q000175:diagnosis / Q000601:surgery / Q000628:therapy*; D011379:Prognosis; D012512:Sarcoma, Ewing / Q000175:diagnosis / Q000601:surgery / Q000628:therapy*; D014750:Vincristine / Q000627:therapeutic use
D003609:Dactinomycin; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide